Medford, MA-based biomaterials provider Serica Technologies was acquired late last year by Allergan, the health care products company that makes onabotulinumtoxinA (Botox). Irvine, CA-based Allergan (NYSE:[[ticker:AGN]]) revealed the buyout in its earnings report yesterday, but did not disclose the acquisition costs. Some of the investors in Serica, which will operate as subsidiary of Allergan in Medford, include Needham, MA-based venture firm Prism VentureWorks, Ivy Capital Partners, of Montvale, NJ, and Morningside Technology Ventures, an investment group with founders from Hong Kong, according to a press release from yesterday.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
